Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	10.77	-7.40	-8.29
Graham Fair Price	0.00	2.17	2.17
PEG	inf	0.00	< 0.005
Price/Book	-16.42	0.17	0.21
Price/Cash Flow	-16.42	58.13	69.54
Prices/Earnings	16.42	-1.36	-1.63
Price/Sales	-16.42	1.59	1.91
Price/FCF	-16.42	58.13	69.54
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	0.00	-0.05	-0.05
Operating Margin	0.00	-0.33	-0.33
ROA	0.00	-0.02	-0.02
ROE	-0.03	-0.03	0.00
ROIC	-0.03	-0.03	0.18
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	0.01	-0.01	0.29
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-21.03	0.00	inf
EPS QOQ	-82.50	0.00	inf
FCF QOQ	1.16	0.00	inf
Revenue QOQ	-0.18	0.00	inf
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	591.60	591.60	0.00
Days Sales Outstanding (DSO)	263.50	263.50	0.00
Inventory Turnover	0.15	0.15	0.00
Debt/Capitalization	0.15	0.15	0.99
Quick Ratio	0.90	0.89	-1.21
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	2.56	2.56	0.00
Cash	0.26	0.24	-5.05
Capex	< 0.005	< 0.005	0.00
Free Cash Flow	< 0.005	< 0.005	0.00
Revenue	0.28	0.28	0.00
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	2.99	2.99	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-2.50	-2.56	-2.32
Naive Interpretation	Member

06 - Financial Health · Bad

Rating